Skip to content

Dianthus Therapeutics, Inc.

DNTH

CIK 0001690585

← back to feed
Revenue (TTM)
$3.92M
−67.3% YoY Q1 May 2026
Net Income (TTM)
−$138.74M
−91.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.52
−64.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-3,948.1%
Q1 May 2026
Net Margin
-3,535.7%
Q1 May 2026
Free Cash Flow (TTM)
−$82.12M
Q1 May 2026
Cash
$627.67M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
54.67M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings